These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 10383161
1. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA. Cancer Res; 1999 Jun 15; 59(12):2957-64. PubMed ID: 10383161 [Abstract] [Full Text] [Related]
2. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Cancer Res; 1996 Jul 01; 56(13):2886-90. PubMed ID: 8674033 [Abstract] [Full Text] [Related]
3. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Schwarze SR, Shi Y, Fu VX, Watson PA, Jarrard DF. Oncogene; 2001 Dec 13; 20(57):8184-92. PubMed ID: 11781834 [Abstract] [Full Text] [Related]
4. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA. Cancer Res; 2000 Jul 15; 60(14):3862-71. PubMed ID: 10919661 [Abstract] [Full Text] [Related]
5. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT, Zheng JW. Int J Oral Maxillofac Surg; 2006 Jul 15; 35(7):653-7. PubMed ID: 16513324 [Abstract] [Full Text] [Related]
6. Increased p16 levels correlate with pRb alterations in human urothelial cells. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C. Cancer Res; 1995 Feb 01; 55(3):493-7. PubMed ID: 7834615 [Abstract] [Full Text] [Related]
7. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. Wadhwa R, Takano S, Taira K, Kaul SC. J Gene Med; 2004 Apr 01; 6(4):439-44. PubMed ID: 15079818 [Abstract] [Full Text] [Related]
8. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL. Cancer Lett; 2007 Jan 08; 245(1-2):184-94. PubMed ID: 16488074 [Abstract] [Full Text] [Related]
9. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D. Oncogene; 2003 Jul 31; 22(31):4831-40. PubMed ID: 12894224 [Abstract] [Full Text] [Related]
10. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382 [Abstract] [Full Text] [Related]
11. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer. Konishi N, Shimada K, Nakamura M, Ishida E, Ota I, Tanaka N, Fujimoto K. Clin Cancer Res; 2008 Jul 15; 14(14):4408-16. PubMed ID: 18628455 [Abstract] [Full Text] [Related]
12. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755 [Abstract] [Full Text] [Related]
13. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP. J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102 [Abstract] [Full Text] [Related]
14. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Brenner AJ, Stampfer MR, Aldaz CM. Oncogene; 1998 Jul 16; 17(2):199-205. PubMed ID: 9674704 [Abstract] [Full Text] [Related]
15. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Oncogene; 2002 Feb 28; 21(10):1510-7. PubMed ID: 11896579 [Abstract] [Full Text] [Related]
16. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H. Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576 [Abstract] [Full Text] [Related]
17. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751 [Abstract] [Full Text] [Related]
18. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T. Anticancer Res; 2000 Mar 15; 20(1A):345-9. PubMed ID: 10769678 [Abstract] [Full Text] [Related]
19. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, von Werder A, Enders GH, Opitz OG, Rustgi AK. Mol Cancer Res; 2003 Aug 15; 1(10):729-38. PubMed ID: 12939398 [Abstract] [Full Text] [Related]
20. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines. Costanzi-Strauss E, Strauss BE, Naviaux RK, Haas M. Exp Cell Res; 1998 Jan 10; 238(1):51-62. PubMed ID: 9457056 [Abstract] [Full Text] [Related] Page: [Next] [New Search]